Mackenzie Financial Corp Cuts Stake in Henry Schein, Inc. (NASDAQ:HSIC)

Mackenzie Financial Corp lessened its holdings in Henry Schein, Inc. (NASDAQ:HSIC) by 5.2% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 8,359 shares of the company’s stock after selling 460 shares during the quarter. Mackenzie Financial Corp’s holdings in Henry Schein were worth $573,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors also recently added to or reduced their stakes in the company. TCW Group Inc. increased its holdings in shares of Henry Schein by 31.3% in the first quarter. TCW Group Inc. now owns 36,877 shares of the company’s stock worth $2,526,000 after buying an additional 8,800 shares during the period. Empirical Finance LLC boosted its position in Henry Schein by 5.9% during the 1st quarter. Empirical Finance LLC now owns 4,855 shares of the company’s stock valued at $333,000 after buying an additional 270 shares during the period. HB Wealth Management LLC grew its holdings in Henry Schein by 1.5% in the 1st quarter. HB Wealth Management LLC now owns 15,419 shares of the company’s stock worth $1,056,000 after acquiring an additional 226 shares during the last quarter. Assetmark Inc. boosted its holdings in shares of Henry Schein by 24,700.0% during the first quarter. Assetmark Inc. now owns 6,200 shares of the company’s stock worth $425,000 after purchasing an additional 6,175 shares during the period. Finally, Cetera Investment Advisers grew its stake in shares of Henry Schein by 14.7% in the first quarter. Cetera Investment Advisers now owns 4,924 shares of the company’s stock worth $337,000 after purchasing an additional 630 shares during the last quarter. Hedge funds and other institutional investors own 96.62% of the company’s stock.

Henry Schein Price Performance

HSIC opened at $66.32 on Thursday. The company’s 50-day simple moving average is $71.27 and its two-hundred day simple moving average is $71.22. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.75 and a current ratio of 1.41. The stock has a market capitalization of $8.07 billion, a P/E ratio of 21.39, a P/E/G ratio of 2.10 and a beta of 0.81. Henry Schein, Inc. has a 52-week low of $60.56 and a 52-week high of $82.49.

Henry Schein (NASDAQ:HSIC) last issued its earnings results on Tuesday, August 5th. The company reported $1.10 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.19 by ($0.09). Henry Schein had a return on equity of 14.36% and a net margin of 3.05%. The company had revenue of $3.24 billion during the quarter, compared to analysts’ expectations of $3.22 billion. During the same quarter in the prior year, the business posted $1.23 EPS. The company’s revenue for the quarter was up 3.3% compared to the same quarter last year. As a group, analysts predict that Henry Schein, Inc. will post 4.74 EPS for the current year.

Wall Street Analyst Weigh In

HSIC has been the subject of several research analyst reports. Stifel Nicolaus reaffirmed a “hold” rating and issued a $75.00 target price (down from $80.00) on shares of Henry Schein in a research report on Friday, July 25th. Baird R W lowered shares of Henry Schein from a “strong-buy” rating to a “hold” rating in a report on Monday, July 14th. Evercore ISI cut their price objective on Henry Schein from $78.00 to $70.00 and set an “in-line” rating on the stock in a research report on Wednesday. Robert W. Baird reissued a “neutral” rating and issued a $72.00 target price (down previously from $82.00) on shares of Henry Schein in a research report on Monday, July 14th. Finally, Barrington Research lowered their target price on Henry Schein from $86.00 to $78.00 and set an “outperform” rating for the company in a research note on Wednesday. Nine research analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $75.92.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.